Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment

By afschroeder • June 19, 2025

Munroe ES, Grandits GA, Hyzy RC, Prescott HC, Barrett TW, Dewar RL, Engen N, Goodman AL, Hatlen TJ, Highbarger H, Holland TL, Hughes G, Jensen TO, Khan MA, Kalomenidis I, Kang N, Laverdure S, Manian P, Menon V, Patel R, Ramachandruni S, Rehman T, Shaw-Saliba K, Røge BT, Vock DM, Weintrob AC, Young BE, Frosch AP; STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups. Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment. PLoS One. 2025 Jun 18;20(6):e0325561. doi: 10.1371/journal.pone.0325561. PMID: 40531973; PMCID: PMC12176123.

Tags: Harbor UCLA, Infectious Diseases, Publications

C3 glomerulopathy post kidney transplantation: A single center experience

Zuckerman J, Pham PT, Parakkal M, Velazquez AF, Sarkar M, Pablos MA, Bunnapradist S, Lum EL. C3 glomerulopathy post kidney transplantation: A single center experience.[...]

The search for the ultra-elusive: Can computed cardiopulmonography enhance early detection of gas exchange abnormality?

Rossiter HB, Molgat-Seon Y. The search for the ultra-elusive: Can computed cardiopulmonography enhance early detection of gas exchange abnormality? Exp Physiol. 2025 Jun 17. doi:[...]

Baseline Cardiac Biomarker Levels as Predictors of Cancer Risk in the MESA Cohort

Cai X, White Q, Johnson WC, Hansen SL, Dardari ZA, Blaha M, Michos ED, Lima JA, deFilippi CR, Budoff MJ, Watson KE, McClelland RL, Yang[...]